tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market
TXMD
TherapeuticsMD
RESEARCH TOOLSreports
Want to see TXMD full AI Analyst Report?

TherapeuticsMD (TXMD) Ratios

2,246 Followers

TherapeuticsMD Ratios

TXMD's free cash flow for Q1 2026 was $0.55. For the 2026 fiscal year, TXMD's free cash flow was decreased by $ and operating cash flow was $-1.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 3.11 3.02 1.92 1.72 1.18
Quick Ratio
 3.11 3.02 1.92 1.72 1.18
Cash Ratio
 1.71 1.56 0.98 0.63 0.81
Solvency Ratio
 0.15 0.06 -0.15 -0.70 2.05
Operating Cash Flow Ratio
 0.54 0.51 0.14 -7.02 -0.09
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.45 0.00 0.00
Net Current Asset Value
$ 4.66M$ 3.67M$ -1.53M$ -2.23M$ 36.00K
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.14 0.18 0.18 0.10
Debt-to-Equity Ratio
 0.18 0.19 0.26 0.27 0.25
Debt-to-Capital Ratio
 0.15 0.16 0.21 0.21 0.20
Long-Term Debt-to-Capital Ratio
 0.15 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.39 1.40 1.42 1.48 2.57
Debt Service Coverage Ratio
 -749.20 0.00 -1.80 0.00 0.00
Interest Coverage Ratio
 -748.80 0.00 -501.05 0.00 0.00
Debt to Market Cap
 0.20 0.00 0.16 0.00 0.00
Interest Debt Per Share
 0.42 0.44 0.62 0.77 0.97
Net Debt to EBITDA
 0.97 0.78 -0.71 -0.45 -2.47
Profitability Margins
Gross Profit Margin
90.31%100.00%100.00%100.00%98.00%
EBIT Margin
-153.21%-139.44%-198.30%-654.61%15.24%
EBITDA Margin
-110.77%-99.97%-169.39%-620.93%16.96%
Operating Profit Margin
-111.66%-139.44%-270.30%-654.61%1.70%
Pretax Profit Margin
3.52%-21.61%-133.05%-594.62%1.54%
Net Profit Margin
5.34%-18.83%-123.85%-789.40%160.08%
Continuous Operations Profit Margin
2.56%-21.61%-131.29%-591.32%1.54%
Net Income Per EBT
151.69%87.14%93.09%132.76%10428.03%
EBT Per EBIT
-3.15%15.50%49.22%90.84%90.18%
Return on Assets (ROA)
0.48%-1.51%-5.62%-23.73%123.81%
Return on Equity (ROE)
0.66%-2.12%-7.97%-35.09%318.69%
Return on Capital Employed (ROCE)
-11.46%-12.82%-14.14%-23.38%2.73%
Return on Invested Capital (ROIC)
-8.35%-12.82%-13.31%-22.35%2.65%
Return on Tangible Assets
0.53%-1.68%-6.32%-27.62%134.10%
Earnings Yield
0.76%-3.02%-21.99%-43.75%221.92%
Efficiency Ratios
Receivables Turnover
 1.04 0.86 0.49 0.42 0.00
Payables Turnover
 21.67 0.00 0.00 0.00 0.65
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.66 0.57 0.29 0.19 9.14
Asset Turnover
 0.09 0.08 0.05 0.03 0.77
Working Capital Turnover Ratio
 0.34 0.42 0.36 0.19 -1.12
Cash Conversion Cycle
 332.70 425.75 738.29 866.24 -564.87
Days of Sales Outstanding
 349.54 425.75 738.29 866.24 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 16.85 0.00 0.00 0.00 564.87
Operating Cycle
 349.54 425.75 738.29 866.24 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 0.23 0.21 0.06 -4.61 -0.45
Free Cash Flow Per Share
 0.23 0.21 0.06 0.00 -0.49
CapEx Per Share
 0.00 0.00 0.00 4.61 0.04
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.00 1.09
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -1.00 -11.49
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -1.00 -11.49
Operating Cash Flow Coverage Ratio
 0.55 0.47 0.10 -6.01 -0.47
Operating Cash Flow to Sales Ratio
 0.80 0.80 0.42 -36.97 -0.06
Free Cash Flow Yield
11.32%12.85%7.38%0.00%-8.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 131.90 -33.14 -4.55 -2.29 0.45
Price-to-Sales (P/S) Ratio
 7.04 6.24 5.63 18.04 0.72
Price-to-Book (P/B) Ratio
 0.88 0.70 0.36 0.80 1.44
Price-to-Free Cash Flow (P/FCF) Ratio
 8.83 7.78 13.55 0.00 -11.38
Price-to-Operating Cash Flow Ratio
 8.83 7.78 13.55 -0.49 -12.38
Price-to-Earnings Growth (PEG) Ratio
 -0.06 0.45 0.07 0.02 >-0.01
Price-to-Fair Value
 0.88 0.70 0.36 0.80 1.44
Enterprise Value Multiple
 -5.39 -5.46 -4.03 -3.36 1.78
Enterprise Value
 20.02M 16.50M 12.03M 27.17M 21.16M
EV to EBITDA
 -5.39 -5.46 -4.03 -3.36 1.78
EV to Sales
 5.97 5.46 6.83 20.87 0.30
EV to Free Cash Flow
 7.49 6.81 16.44 0.00 -4.77
EV to Operating Cash Flow
 7.49 6.81 16.44 -0.56 -5.19
Tangible Book Value Per Share
 2.01 2.00 2.00 2.22 3.12
Shareholders’ Equity Per Share
 2.33 2.32 2.37 2.80 3.89
Tax and Other Ratios
Effective Tax Rate
 0.27 0.00 0.01 <0.01 0.00
Revenue Per Share
 0.29 0.26 0.15 0.12 7.75
Net Income Per Share
 0.02 -0.05 -0.19 -0.98 12.41
Tax Burden
 1.52 0.87 0.93 1.33 104.28
Interest Burden
 -0.02 0.15 0.67 0.91 0.10
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 1.54 2.27 0.00 0.00 0.83
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.17
Income Quality
 31.09 -3.71 -0.32 6.25 -3.80
Currency in USD